Clinical Trial Update: Impact of Suvorexant on Sympathetic Nerve Activity and Baroreflex Function in Chronic Insomnia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating the impact of suvorexant on sympathetic nerve activity and baroreflex function in chronic insomnia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Suvorexant (suvorexant)

Snippet

Sponsor: Montana State University | Conditions: Chronic Insomnia | Phase 4 | Status: UNKNOWN